Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mark Skeen"'
Autor:
Suma Shah, Anastasie Dunn-Pirio, Matthew Luedke, Joel Morgenlander, Mark Skeen, Christopher Eckstein
Publikováno v:
Case Reports in Neurological Medicine, Vol 2018 (2018)
Immune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malignancies. However, they can cause a number of immune-related adverse effects (irAEs) through lymphocyte dysregulation. Central nervous system (CNS) irAE
Externí odkaz:
https://doaj.org/article/58547532381c4f8b80de833e5e527bed
Autor:
Paige Sutton, Michael W. Lutz, F. Lee Hartsell, Dorlan Kimbrough, N. Troy Tagg, Mark Skeen, Nicholas M. Hudak, Christopher Eckstein, Suma Shah
Publikováno v:
Journal of neuroimmunology. 373
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a chronic demyelinating disorder that has been increasingly recognized since the serum antibody became commercially available in 2017. The most common clinical presentation is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2459228a11ef65252cdb44cd908cdd0b
https://pubmed.ncbi.nlm.nih.gov/36272183
https://pubmed.ncbi.nlm.nih.gov/36272183
Publikováno v:
Current Opinion in Endocrinology & Diabetes. 8:205-212
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e2b5a938448c56cf94c3dd08ccd39b79
https://doi.org/10.1097/00060793-200108000-00007
https://doi.org/10.1097/00060793-200108000-00007